High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myelomaBruno Paiva, Jesús F. San Miguel, María‐Victoria Mateos et al.|Blood|2011Cited by 304
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myelomaLaura Rosiñol, Joan Bladé, Josè Antonio Pérez-Simón et al.|Blood|2008Cited by 264
Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose TherapyGema Mateo, Jesús F. San Miguel, María-Ángeles Montalbán et al.|Journal of Clinical Oncology|2008Cited by 210
Genetic Abnormalities and Patterns of Antigenic Expression in Multiple MyelomaGema Mateo, Jesús F. San Miguel, Mariana Castellanos et al.|Clinical Cancer Research|2005Cited by 126
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenanceMaría‐Victoria Mateos, Jesús F. San Miguel, Norma C. Gutiérrez et al.|Blood|2011Cited by 58